To date, clinical implications of the <i>PIK3CA</i> N345K variant remain insufficiently investigated; however, everolimus treatment resulted in the shrinkage of tumor lesions and decreased the levels of tumor markers. This evidence concerns the gene PIK3CA and neoplasm.